Study on Nivolumab in Neuroblastoma
Condition:   Recurrent Stage IV High Risk Neuroblastoma Intervention:   Drug: Nivolumab Sponsor:   Shanghai Children's Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 2, 2020 Category: Research Source Type: clinical trials

Treatment With Dinutuximab in Combination With Irinotecan and Temozolomide After Intensive Therapy for People With High-Risk Neuroblastoma
Conditions:   Ganglioneuroblastoma, Nodular;   High-Risk Neuroblastoma Interventions:   Biological: Dinutuximab;   Drug: Irinotecan;   Drug: Isotretinoin;   Biological: Sargramostim;   Drug: Temozolomide Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2020 Category: Research Source Type: clinical trials

Flavored, Oral Irinotecan (VAL-413) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Conditions:   Solid Tumors;   Neuroblastoma;   Rhabdomyosarcoma;   Ewing Sarcoma;   Hepatoblastoma;   Medulloblastoma Interventions:   Drug: VAL-413;   Drug: Temozolomide Sponsor:   Valent Technologies, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 7, 2020 Category: Research Source Type: clinical trials

Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment Trial
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Recurrent Ependymoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Histiocytic and Dendritic Cell Neoplasm;   Recurrent Langerhans Cell Histiocytosis;   Recurrent Lymphoma;   Recurrent Malignant Germ Cel l Tumor;   Recurrent Malignant Glioma;   Recurrent Malignant Solid Neoplasm;   Recurrent Medulloblastoma;   Recurrent Neuroblastoma;   Recurr...
Source: ClinicalTrials.gov - March 25, 2020 Category: Research Source Type: clinical trials

Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Conditions:   Ewing Sarcoma;   Rhabdomyosarcoma;   Wilms Tumor;   Neuroblastoma;   Hepatoblastoma;   Germ Cell Tumor Intervention:   Drug: Vorinostat Sponsor:   New York Medical College Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 16, 2020 Category: Research Source Type: clinical trials